EP0614653B1 - Fluid delivery system - Google Patents
Fluid delivery system Download PDFInfo
- Publication number
- EP0614653B1 EP0614653B1 EP19940300847 EP94300847A EP0614653B1 EP 0614653 B1 EP0614653 B1 EP 0614653B1 EP 19940300847 EP19940300847 EP 19940300847 EP 94300847 A EP94300847 A EP 94300847A EP 0614653 B1 EP0614653 B1 EP 0614653B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- container
- vial
- capsule
- plug
- cannula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000012530 fluid Substances 0.000 title claims abstract description 23
- 239000002775 capsule Substances 0.000 claims abstract description 60
- 239000003814 drug Substances 0.000 claims abstract description 40
- 239000007788 liquid Substances 0.000 claims description 13
- 238000005192 partition Methods 0.000 claims description 9
- 239000000126 substance Substances 0.000 claims description 5
- 238000004891 communication Methods 0.000 claims description 4
- 239000003085 diluting agent Substances 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- 238000003780 insertion Methods 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000007789 sealing Methods 0.000 abstract description 3
- 229920003002 synthetic resin Polymers 0.000 description 9
- 239000000057 synthetic resin Substances 0.000 description 9
- -1 polyethylene Polymers 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 238000011109 contamination Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 229920003217 poly(methylsilsesquioxane) Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
- B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
- B65D81/3205—Separate rigid or semi-rigid containers joined to each other at their external surfaces
- B65D81/3211—Separate rigid or semi-rigid containers joined to each other at their external surfaces coaxially and provided with means facilitating admixture
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/2013—Piercing means having two piercing ends
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2055—Connecting means having gripping means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2048—Connecting means
- A61J1/2065—Connecting means having aligning and guiding means
Definitions
- This invention relates to a fluid delivery system, and more particularly, to such a fluid delivery system including a vial for containing therein a substance, preferably a powder, such as medicament or drug, and a container for containing therein a fluid, preferably a liquid, such as solution or diluent, to mix the powder with the liquid.
- dry medicament such as powdered medicament or freeze-dried medicament
- a container such as a vial
- the vial containing the medicament and another container containing a solution or diluent are connected to each other by means of a double-pointed hollow needle or any other communicating pipe, so that the solution is transferred to the vial containing the medicament to dissolve the latter.
- JP-A-61/501129 which corresponds to US-A-4,583,971
- JP-A-2 1277 which corresponds to US-A-4,936,841
- JP-A-3-37067 A fluid storage and delivery system which cannot expect a complete sterile operation, but capable of optionally selecting the combinations between the medicament and solution and attaining a substantially sterile operation, has been proposed, such as disclosed in Japanese Unexamined Patent Publications (JP-A) Nos. 59-209535, 62-137056, and 2-4375, or also Japanese Examined Patent Publications (kokoku) No. 2-26506.
- a capsule accommodating a medicament container and a flexible container containing a solution are connected to each other by a tube, in such a manner that the medicament container is mutually communicated with the flexible container by communicating means provided in the tube and therefore the medicament is mixed with the solution in a sterile condition.
- capsule accommodating a medicament container is connected by its connecting portion to an opening of a solution container.
- the connecting portion of the capsule is accompanied with a communicating means providing with a means for controlling the connection order, in such a manner that the medicament container is first pierced by the communicating means and then the solution container is pierced so that the two containers are mutually communicated by the communicating means and therefore the medicament is mixed with the solution in a sterile condition.
- a medicament container, a communicating means and a solution container are arranged in such an order and covered air tightly with a sheet made of synthetic resin.
- a container support means is provided between the medicament container and the solution container for supporting them over the sheet, so that the medicament container and the solution container are prevented from accessing toward each other until they are mutually communicated in a sterile condition.
- JP-A 59-209535 discloses a system comprising a first hermetically sealed flexible container having a flexible wall member, a second container having a detachable stopper and which can be fixed through the wall member, and a stopper detaching means having a portion engaged with the stopper. The stopper comes into engaged with the stopper detaching means through the first and second containers and then the stopper is removed from the second container together with a sealing barrier of the first flexible container, so that the two containers are mutually communicated to allow the mixing of the contents in these containers.
- JP-A 62-137056 and JP-A 2-4375 disclose a system in which the above-mentioned second container is improved.
- JP-A 2-26506 discloses a further improved system of that disclosed in the above-mentioned JP-A 59-209535.
- Unexamined Patent Publication (JP-A) No. 4-329956 discloses a sterile mixing apparatus of medicament container in a sealed vial, the apparatus comprising a vial containing therein a medicament, a liquid container, pierceable plug members for hermetically sealing the openings of the vial and the container, respectively, a cannula member having respective edges at both sides.
- the general aim herein is to provide a novel fluid delivery system, which desirably can be easily and surely handled by an operator, such as a doctor, nurse or the like, in a sterile or substantially sterile condition and has a simple construction as compared with the above-mentioned systems known in the prior art.
- said container has a cylindrical wall portion and a bottom, an auxiliary cover member is put onto said container to air tightly cover said cylindrical wall portion and said bottom thereof, and said cover member is frictionally and slidably fit within said sleeve, when said container is inserted into said sleeve.
- FIGs. 1, 2, and 3 show several embodiments of a fluid delivery system using the present proposals.
- the system comprises a fluid container 1, a vial 2, a sliding member 3 having a double-pointed cannula and a cylindrical or pipe-like capsule or sleeve 4.
- the capsule 4 has a partition wall 41 having a central opening 42 to separate this capsule 4 into two sections 43 and 44, i.e., an upper, slide section 43 having an inner cylindrical bore, within which the sliding member 3 is slidably disposed, and has an upper open end through which the solution container 1 is slidably inserted, and a lower, vial mount section 44 having a bottom open end to which the vial 2 is detachably and fixedly connected.
- the capsule 4 may be made of any suitable synthetic resin, such as polyethylene, polypropylene, polyester or the like.
- the solution container 1 is substantially cylindrical and usually made of glass or synthetic resin, such as polyethylene, polypropylene, polyester or the like.
- the container 1 has an inlet opening 11 through which any suitable liquid, such as solution or diluent for transfusion, is filled and then the opening 11 is hermetically sealed by a pierceable rubber plug 12.
- the container 1 has a cylindrical wall portion and a bottom and it is preferable that the container 1 is sheathed within an auxiliary sliding cover 5 to air-tightly cover the cylindrical wall portion and the bottom of the container 1.
- the cover 5 is not always necessary to cover entirely the bottom of the container 1, but may be provided with a central open area 51 as illustrated in Fig. 1, although at least the peripheral area of the bottom must be tightly covered by the auxiliary cover 5.
- Such an auxiliary sliding cover 5 may be made of any suitable material, such as synthetic resin, for example polypropylene, polyethylene, polyvinyl chloride or the like, so that the auxiliary sliding cover 5 is frictionally, air tightly and slidably fit within the capsule 4 when the container 1 is inserted into the capsule 4.
- the capsule 4 is provided with an annular rib 45 on the inner wall thereof. Therefore, an annular edge of the cover 5 first comes into engagement with the annular rib 45 to retain the container 1 within the capsule 4 when the solution container 1 is inserted into the capsule 4. Thus, the solution container 4 is prevented from unintentionally falling down. As described hereinafter in detail, when the container is further pushed down, the cover 5 is allowed to move over the annular rib 45.
- the vial 2 is substantially cylindrical and usually made of glass, and has an inlet opening 21 through which the vial 2 is filled with any suitable substance, such as a dry medicament or drug, for example powdered medicament or freeze-dried medicament, not shown in the drawings.
- the inlet opening 21 is hermetically sealed by a pierceable rubber plug 22.
- the vial 2 is provided with a male thread portion 23 around the inlet opening 21 and, on the other hand, the vial mount section 44 of the capsule 4 provided with a female thread portion 46, so that the vial 1 can be detachably and fixedly connected to the vial mount section 44 of the capsule 4 by the thread connection.
- the male and female thread portions 23, 46 are arranged in such a manner that, when the vial 1 is fixedly connected to the capsule 4 by the thread connection, the upper surface of the rubber plug 22 of the vial 2 comes into contact with the radial partition wall 41.
- the sliding member 3 is disposed in the slide section 43 of the capsule 4 so that the sliding member 3 is slidably movable in the axial direction within the cylindrical bore of the capsule 4.
- the sliding member 3 comprises a cannula provided with upper and lower needles 33, 34 extending axially toward the upper container 1 and lower vial 2 respectively, a hub 31 and several (four, in the embodiment shown in Figs. 4 - 6) slide arms 32 extending axially from the periphery of the hub 31.
- the hub 31 and the slide arms 32 are integrally formed of any suitable synthetic resin as a single unit.
- the cannula is usually made of stainless steel, preferably SUS 304, or any hard synthetic resin, providing upper and lower needles 33, 34 extending axially up and down toward the container 1 and vial 2, respectively.
- the hub 31 is usually made of any suitable synthetic resin.
- the cannula should be made of stainless steel.
- the cannula should be made of hard synthetic resin, such as ABS resin or polycarbonate.
- the sliding member 3 including the cannula, the hub 31 and the slide arms 32 can be integrally formed as a single unit.
- the sliding member 3 When assembling this system, the sliding member 3 is first inserted into the slide section 43 of the capsule 4 so that the slide arms 32 are slidably engaged with the inner bore wall of the capsule 5 to retain the sliding member 3 within the capsule 4. Then, container 1 covered with the auxiliary cover 5 as mentioned above is inserted into the capsule 4 until the annular edge of the cover 5 comes into engagement with the annular rib 45. Thus, the container 1 is retained within the capsule 4 so that the solution container 4 is prevented from unintentionally falling down. In this state, if necessary, the container 1 can also be sold and available in the market as a single product or commodity.
- the vial 2 containing the medicament therein is connected to the capsule 4, as mentioned above and shown in Figs. 1 - 3, by an operator, such as a doctor or nurse, so that the vial 2 and the capsule 4 are fixed to each other by the thread engagement.
- the container 1 is pushed down so that the cover 5 moves past the annular rib 45.
- the sliding member 3 is further moved downward with the container 1 and then the lower needle 34 of the cannula comes into contact with rubber plug 22 of the vial 2 through the central opening 42 of the partition wall 41.
- the movement of the sliding member 3 is controlled in such a manner that the lower needle 34 of the cannula first sealingly pierces and is inserted into the rubber plug 22 of the vial 2, so that the cannula communicates with the vial 2, and then the upper needle 33 of the cannula sealingly pierces and is inserted into the rubber plug 12 of the fluid container 1 so that both the fluid container 1 and the vial 2 are communicated to each other through the cannula.
- the cannula in such a manner that the edge of lower needle 34 is made sharper than that of the upper needle 33.
- the rubber plug 12 of the container 1 is made harder than the rubber plug 22 of the vial 2.
- a rubber cap 6 is attached to cover the lower needle 34 of the cannula which would prevent a leak of solution from the container 1 through the cannula, if the upper needle 33 was inserted into the rubber plug 12 of the container 1 to communicate with the container 1, before the lower needle 34 was pierced into the rubber plug 22 of the vial 2.
- the sliding member 3 is provided with braking means to prevent a leak of solution from the container 1.
- braking means comprises several legs 7 integrally extending from the hub 31 of the sliding member 3 and engaged with the opening portion of the container 1 by projections 8 of the legs 7. Therefore, when the container 1 is pushed down, the sliding member 3 descends with the container 1 until the lower needle 34 of the cannula comes into contact with and pierces the rubber plug 22 of the vial 2 so that the cannula communicates with the vial 2.
- the container 1 is moved over the projections 8 of the legs 7 and allowed to move downward so as to widen the legs 7, until the upper needle 33 penetrates the rubber plug 12 of the container 1 to communicate with the container 1.
- a stopper means such as an annular recess or undercut portion 47 is formed on an inner wall of the capsule 4. Therefore, when the sliding member 3 is completely lowered to a predetermined position, in other words, when the sliding member 3 comes into contact with the radial partition wall 42, the slide arms 32 of sliding member 3 come to be engaged with the recess 47 and thus the sliding member 3 is locked.
- the recess 47 is preferably formed as a sharp edge and the ends of the slide arms 32 are provided with hook portions 35, as shown in Figs. 4 - 6, which can be securely engaged with the recess 47.
- the liquid or solution in the container 1 enters the vial 2 and the powdered medicament or freeze-dried medicament is mixed with or dissolved in the solution.
- the vial 2 is removed from the capsule 4.
- the vial 2 containing the medicament solution is used in the transfusion for a patient.
- the remaining system including the container 1, the sliding member 3 and the capsule 4 are usually disposed of.
- the lower needle 34 does not protrude from the lower end 48 of the sleeve, as shown in Fig. 1, and thus a safe handling of the system can be ensured after the vial 1 is removed.
- the cannula of the sliding member 3 has a single fluid passage 36, as shown in Figs. 4 - 6, a cannula having two such passages 37, 38 may be used, as shown in Fig. 7.
- the solution can be more rapidly transferred from the container 1 to the vial, since one of the passages 37, 38 is used as a liquid way and the other is used as an air/gas way.
- both the capsule 4 and the auxiliary cover 5 are made of synthetic resin, the auxiliary cover 5 is a frictional and air-tight fit within the capsule 4, even if the mutual dimensions therebetween have not been very strictly controlled. Therefore, any possible contamination is effectively prevented and, particularly, unfavorable substances such as bacteria are prevented from entering into the slide section 43 of the capsule 4.
- the fluid delivery system described above can easily be handled even if the operator is not familiar with the solution for transfusion and dry medicament in this field. Also, any possible errors in the delivery of mixing process for providing the patient can effectively be prevented.
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mechanical Engineering (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Details Of Rigid Or Semi-Rigid Containers (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
- This invention relates to a fluid delivery system, and more particularly, to such a fluid delivery system including a vial for containing therein a substance, preferably a powder, such as medicament or drug, and a container for containing therein a fluid, preferably a liquid, such as solution or diluent, to mix the powder with the liquid.
- In hospitals or other health care facilities, dry medicament, such as powdered medicament or freeze-dried medicament, packaged within a container, such as a vial, has been conventionally used in such a manner that the medicament is mixed with or dissolved in a solution, which is to be provided for fluid therapy. In this case, the vial containing the medicament and another container containing a solution or diluent are connected to each other by means of a double-pointed hollow needle or any other communicating pipe, so that the solution is transferred to the vial containing the medicament to dissolve the latter.
- However, such an operation requires laborious and troublesome effort and there is a fear of contamination because a hole for connection is formed in the drug container in the open air.
- To solve such problems, a fluid delivery system having an object of carrying out an operation in a completely sterile condition has been proposed, such as disclosed in JP-A-61/501129 (which corresponds to US-A-4,583,971), JP-A-2 1277 (which corresponds to US-A-4,936,841), and JP-A-3-37067. A fluid storage and delivery system which cannot expect a complete sterile operation, but capable of optionally selecting the combinations between the medicament and solution and attaining a substantially sterile operation, has been proposed, such as disclosed in Japanese Unexamined Patent Publications (JP-A) Nos. 59-209535, 62-137056, and 2-4375, or also Japanese Examined Patent Publications (kokoku) No. 2-26506.
- In the above-mentioned JP-A 61-501129, a capsule accommodating a medicament container and a flexible container containing a solution are connected to each other by a tube, in such a manner that the medicament container is mutually communicated with the flexible container by communicating means provided in the tube and therefore the medicament is mixed with the solution in a sterile condition. In JP-A 2-1277, capsule accommodating a medicament container is connected by its connecting portion to an opening of a solution container. The connecting portion of the capsule is accompanied with a communicating means providing with a means for controlling the connection order, in such a manner that the medicament container is first pierced by the communicating means and then the solution container is pierced so that the two containers are mutually communicated by the communicating means and therefore the medicament is mixed with the solution in a sterile condition. In JP-A 3-37067, a medicament container, a communicating means and a solution container are arranged in such an order and covered air tightly with a sheet made of synthetic resin. A container support means is provided between the medicament container and the solution container for supporting them over the sheet, so that the medicament container and the solution container are prevented from accessing toward each other until they are mutually communicated in a sterile condition.
- On the other hand, JP-A 59-209535 discloses a system comprising a first hermetically sealed flexible container having a flexible wall member, a second container having a detachable stopper and which can be fixed through the wall member, and a stopper detaching means having a portion engaged with the stopper. The stopper comes into engaged with the stopper detaching means through the first and second containers and then the stopper is removed from the second container together with a sealing barrier of the first flexible container, so that the two containers are mutually communicated to allow the mixing of the contents in these containers. JP-A 62-137056 and JP-A 2-4375 disclose a system in which the above-mentioned second container is improved. Also, JP-A 2-26506 discloses a further improved system of that disclosed in the above-mentioned JP-A 59-209535.
- Also, Unexamined Patent Publication (JP-A) No. 4-329956 discloses a sterile mixing apparatus of medicament container in a sealed vial, the apparatus comprising a vial containing therein a medicament, a liquid container, pierceable plug members for hermetically sealing the openings of the vial and the container, respectively, a cannula member having respective edges at both sides. When the vial is pushed down to said container, one of needle tips of the cannula is first pierced and inserted into the medicament vial and then the other needle tip of the cannula is pierced to the fluid container, so that the medicament vial and the fluid container are communicated to each other through the cannula.
- However, in the former system as disclosed in JP-A 61-501129, since a pair of the medicament container and the solution container are constructed as one unit, an operation in a complete sterile condition can be attained, although the kind of medicament which can be used in this system is restricted. On the other hand, the system disclosed in JP-A 59-209535 is relatively complicate in construction and has some drawbacks. For example, the stopper is undesirably dropped in the first container. It is difficult to obtain an operation in a complete sterile operation, although a substantially sterile operation can be attained. Also, since combination between the medicament container and the solution container can optionally be selected, suitable managing and handling would strongly be required in the medical field.
- In the system disclosed JP-A 4-329956, on which prior art the preamble of claim 1 is based, a special mechanism or means is necessary for retaining the medicament vial so as not to communicate with liquid container until the vial is intentionally pushed down to toward the container by an operator.
- The general aim herein is to provide a novel fluid delivery system, which desirably can be easily and surely handled by an operator, such as a doctor, nurse or the like, in a sterile or substantially sterile condition and has a simple construction as compared with the above-mentioned systems known in the prior art.
- What we propose herein, as set out in claim 1, is a fluid delivery system comprising
- a vial to contain a substance for dissolving in a liquid, the vial having an opening and a first pierceable plug member providing a hermetically-sealed closure of the vial opening;
- a container for the liquid, the container having an opening and a second pierceable plug member providing a hermetically-sealed closure of the container opening;
- a capsule having a first open end at which the vial is releasably connected and a second open end at which the container is inserted, and
- a slide member disposed slidably in the capsule, having a double-pointed cannula with lower and upper cannula needles axially directed respectively towards the first and second ends of the capsule;
- control means being provided to control the movement of the slide member; characterised in that
-
- It is preferable that said container has a cylindrical wall portion and a bottom, an auxiliary cover member is put onto said container to air tightly cover said cylindrical wall portion and said bottom thereof, and said cover member is frictionally and slidably fit within said sleeve, when said container is inserted into said sleeve.
-
- Figure 1 is a cross-sectional view of a first embodiment of a fluid delivery system;
- Figure 2 is a cross-sectional view of another embodiment of the system similar to that of Fig. 1;
- Figure 3 is a cross-sectional view of a further embodiment of the system;
- Figure 4 is a cross-sectional view of a sliding member having a double-pointed cannula used in this system;
- Figure 5 is a bottom plan view of the sliding member shown in Fig. 4;
- Figure 6 is a top plan view of the sliding member; and
- Figure 7 is a cross-sectional view of a sliding member having another cannula.
-
- Referring now to the drawings, wherein Figs. 1, 2, and 3 show several embodiments of a fluid delivery system using the present proposals. The system comprises a fluid container 1, a
vial 2, a slidingmember 3 having a double-pointed cannula and a cylindrical or pipe-like capsule orsleeve 4. - The
capsule 4 has apartition wall 41 having acentral opening 42 to separate thiscapsule 4 into twosections slide section 43 having an inner cylindrical bore, within which thesliding member 3 is slidably disposed, and has an upper open end through which the solution container 1 is slidably inserted, and a lower,vial mount section 44 having a bottom open end to which thevial 2 is detachably and fixedly connected. Thecapsule 4 may be made of any suitable synthetic resin, such as polyethylene, polypropylene, polyester or the like. - The solution container 1 is substantially cylindrical and usually made of glass or synthetic resin, such as polyethylene, polypropylene, polyester or the like. The container 1 has an inlet opening 11 through which any suitable liquid, such as solution or diluent for transfusion, is filled and then the
opening 11 is hermetically sealed by apierceable rubber plug 12. - The container 1 has a cylindrical wall portion and a bottom and it is preferable that the container 1 is sheathed within an auxiliary sliding
cover 5 to air-tightly cover the cylindrical wall portion and the bottom of the container 1. Thecover 5 is not always necessary to cover entirely the bottom of the container 1, but may be provided with a centralopen area 51 as illustrated in Fig. 1, although at least the peripheral area of the bottom must be tightly covered by theauxiliary cover 5. - Such an auxiliary sliding
cover 5 may be made of any suitable material, such as synthetic resin, for example polypropylene, polyethylene, polyvinyl chloride or the like, so that the auxiliary slidingcover 5 is frictionally, air tightly and slidably fit within thecapsule 4 when the container 1 is inserted into thecapsule 4. In addition, thecapsule 4 is provided with anannular rib 45 on the inner wall thereof. Therefore, an annular edge of thecover 5 first comes into engagement with theannular rib 45 to retain the container 1 within thecapsule 4 when the solution container 1 is inserted into thecapsule 4. Thus, thesolution container 4 is prevented from unintentionally falling down. As described hereinafter in detail, when the container is further pushed down, thecover 5 is allowed to move over theannular rib 45. - The
vial 2 is substantially cylindrical and usually made of glass, and has an inlet opening 21 through which thevial 2 is filled with any suitable substance, such as a dry medicament or drug, for example powdered medicament or freeze-dried medicament, not shown in the drawings. The inlet opening 21 is hermetically sealed by apierceable rubber plug 22. Thevial 2 is provided with amale thread portion 23 around the inlet opening 21 and, on the other hand, thevial mount section 44 of thecapsule 4 provided with afemale thread portion 46, so that the vial 1 can be detachably and fixedly connected to thevial mount section 44 of thecapsule 4 by the thread connection. The male andfemale thread portions capsule 4 by the thread connection, the upper surface of therubber plug 22 of thevial 2 comes into contact with theradial partition wall 41. - The sliding
member 3 is disposed in theslide section 43 of thecapsule 4 so that the slidingmember 3 is slidably movable in the axial direction within the cylindrical bore of thecapsule 4. As also shown in Figs. 4 - 6, the slidingmember 3 comprises a cannula provided with upper andlower needles lower vial 2 respectively, ahub 31 and several (four, in the embodiment shown in Figs. 4 - 6)slide arms 32 extending axially from the periphery of thehub 31. Thehub 31 and theslide arms 32 are integrally formed of any suitable synthetic resin as a single unit. The cannula is usually made of stainless steel, preferably SUS 304, or any hard synthetic resin, providing upper andlower needles vial 2, respectively. Thehub 31 is usually made of any suitable synthetic resin. - If a sharpness or piercing property of the cannula is to be an important factor, the cannula should be made of stainless steel. On the other hand, if a disposable property of the cannula is to be an important factor, the cannula should be made of hard synthetic resin, such as ABS resin or polycarbonate. In this case, the sliding
member 3 including the cannula, thehub 31 and theslide arms 32 can be integrally formed as a single unit. - When assembling this system, the sliding
member 3 is first inserted into theslide section 43 of thecapsule 4 so that theslide arms 32 are slidably engaged with the inner bore wall of thecapsule 5 to retain the slidingmember 3 within thecapsule 4. Then, container 1 covered with theauxiliary cover 5 as mentioned above is inserted into thecapsule 4 until the annular edge of thecover 5 comes into engagement with theannular rib 45. Thus, the container 1 is retained within thecapsule 4 so that thesolution container 4 is prevented from unintentionally falling down. In this state, if necessary, the container 1 can also be sold and available in the market as a single product or commodity. - Usually, in the hospitals or other health care facilities, the
vial 2 containing the medicament therein is connected to thecapsule 4, as mentioned above and shown in Figs. 1 - 3, by an operator, such as a doctor or nurse, so that thevial 2 and thecapsule 4 are fixed to each other by the thread engagement. Then, the container 1 is pushed down so that thecover 5 moves past theannular rib 45. After therubber plug 12 of the container 1 comes into contact with theupper needle 33 of the cannula, the slidingmember 3 is further moved downward with the container 1 and then thelower needle 34 of the cannula comes into contact withrubber plug 22 of thevial 2 through thecentral opening 42 of thepartition wall 41. - Then, according to the present invention, the movement of the sliding
member 3 is controlled in such a manner that thelower needle 34 of the cannula first sealingly pierces and is inserted into therubber plug 22 of thevial 2, so that the cannula communicates with thevial 2, and then theupper needle 33 of the cannula sealingly pierces and is inserted into therubber plug 12 of the fluid container 1 so that both the fluid container 1 and thevial 2 are communicated to each other through the cannula. - In order to ensure such an operation, it is preferable to form the cannula in such a manner that the edge of
lower needle 34 is made sharper than that of theupper needle 33. In another embodiment, therubber plug 12 of the container 1 is made harder than therubber plug 22 of thevial 2. - In the embodiment shown in Fig. 2, a
rubber cap 6 is attached to cover thelower needle 34 of the cannula which would prevent a leak of solution from the container 1 through the cannula, if theupper needle 33 was inserted into therubber plug 12 of the container 1 to communicate with the container 1, before thelower needle 34 was pierced into therubber plug 22 of thevial 2. - However, in the embodiment shown in Fig. 3, the sliding
member 3 is provided with braking means to prevent a leak of solution from the container 1. Such braking means comprisesseveral legs 7 integrally extending from thehub 31 of the slidingmember 3 and engaged with the opening portion of the container 1 byprojections 8 of thelegs 7. Therefore, when the container 1 is pushed down, the slidingmember 3 descends with the container 1 until thelower needle 34 of the cannula comes into contact with and pierces therubber plug 22 of thevial 2 so that the cannula communicates with thevial 2. After thehub 31 of the slidingmember 3 comes into contact with thepartition wall 41, the container 1 is moved over theprojections 8 of thelegs 7 and allowed to move downward so as to widen thelegs 7, until theupper needle 33 penetrates therubber plug 12 of the container 1 to communicate with the container 1. - Also, as shown in the embodiments shown in Figs. 2 and 3, a stopper means, such as an annular recess or undercut
portion 47 is formed on an inner wall of thecapsule 4. Therefore, when the slidingmember 3 is completely lowered to a predetermined position, in other words, when the slidingmember 3 comes into contact with theradial partition wall 42, theslide arms 32 of slidingmember 3 come to be engaged with therecess 47 and thus the slidingmember 3 is locked. To more firmly lock the slidingmember 3, therecess 47 is preferably formed as a sharp edge and the ends of theslide arms 32 are provided withhook portions 35, as shown in Figs. 4 - 6, which can be securely engaged with therecess 47. Thus, once the slidingmember 3 is locked, unfavorable movement thereof such as a raise or kick-back due to an elastic force of therubber cap 6 can effectively be prevented. - Thus, the liquid or solution in the container 1 enters the
vial 2 and the powdered medicament or freeze-dried medicament is mixed with or dissolved in the solution. After the solution in the container 1 is completely transferred to thevial 2, thevial 2 is removed from thecapsule 4. Then, thevial 2 containing the medicament solution is used in the transfusion for a patient. The remaining system including the container 1, the slidingmember 3 and thecapsule 4 are usually disposed of. In this case, it is preferable that thelower needle 34 does not protrude from thelower end 48 of the sleeve, as shown in Fig. 1, and thus a safe handling of the system can be ensured after the vial 1 is removed. - Although in the above-mentioned embodiment, the cannula of the sliding
member 3 has asingle fluid passage 36, as shown in Figs. 4 - 6, a cannula having twosuch passages passages - As mentioned above, according to the above-mentioned embodiment, since both the
capsule 4 and theauxiliary cover 5 are made of synthetic resin, theauxiliary cover 5 is a frictional and air-tight fit within thecapsule 4, even if the mutual dimensions therebetween have not been very strictly controlled. Therefore, any possible contamination is effectively prevented and, particularly, unfavorable substances such as bacteria are prevented from entering into theslide section 43 of thecapsule 4. - Also, since the movement of the sliding
member 3 is controlled in such a manner that thelower needle 34 of the cannula first pierces and communicates with thevial 2 and then theupper needle 33 of the cannula pierces therubber plug 12 of the fluid container 1 so that both the fluid container 1 and thevial 2 are communicated to each other through the cannula. Therefore, a safe operation can be attained in a sterile condition with the system having a relatively simple and less expensive construction. - Therefore, the fluid delivery system described above can easily be handled even if the operator is not familiar with the solution for transfusion and dry medicament in this field. Also, any possible errors in the delivery of mixing process for providing the patient can effectively be prevented.
the vial has an axially-fixed connection at the first end of the capsule whereas the container is inserted axially slidably at the second end, such that when the container is pushed it slides into the capsule and pushes the slide member along the capsule, the control means being such that when the container and vial are moved towards one another the lower cannula needle pierces the first plug member of the vial to put the cannula in communication with the vial interior before the upper cannula needle pierces the second plug member of the container to put the vial interior in communication with the container interior.
Claims (16)
- A fluid delivery system comprisinga vial (2) to contain a substance for dissolving in a liquid, the vial (2) having an opening (21) and a first pierceable plug member (22) providing a hermetically-sealed closure of the vial opening (21);a container (1) for the liquid, the container (1) having an opening (11) and a second pierceable plug member (12) providing a hermetically-sealed closure of the container opening (11);a capsule (4) having a first open end at which the vial (2) is releasably connected and a second open end at which the container (1) is inserted, anda slide member (3) disposed slidably in the capsule (4), having a double-pointed cannula with lower and upper cannula needles (34,33) axially directed respectively towards the first and second ends of the capsule (4);control means being provided to control the movement of the slide member (3);
the vial (2) has an axially-fixed connection at the first end of the capsule (4) whereas the container (1) is inserted axially slidably at the second end, such that when the container (1) is pushed it slides into the capsule (4) and pushes the slide member (3) along the capsule, the control means being such that when the container and vial are moved towards one another the lower cannula needle (34) pierces the first plug member (22) of the vial (2) to put the cannula in communication with the vial interior before the upper cannula needle (33) pierces the second plug member (12) of the container (1) to put the vial interior in communication with the container interior. - A system according to claim 1 in which the container (1) contains the liquid and the vial (2) contains a powder.
- A system according to claim 2 in which the liquid is a solution or diluent for transfusion.
- A system according to claim 2 or claim 3 in which the powder is a medicament or drug.
- A system according to any one of the preceding claims in which the control means includes an edge of the lower cannula needle (34) being formed sharper than an edge of the upper cannula needle (33).
- A system according to any one of claims 1 to 4 in which the first and second plug members (12,22) are rubber, and the control means includes the second plug member (22) of the vial (2) being harder than the first plug member (12) of the container (1).
- A system according to any one of claims 1 to 4 in which the control means includes a braking means (7,8) attached to the slide member (3), the braking means (7,8) being engageable with the container (1) in such a way that, when the container (1) is pushed towards the vial (2) the slide member (3) moves towards the vial (2) with the container (1) for piercing of the first plug (22) of vial (2), continued pushing of the container (1) then overriding the braking means (7,8) for the piercing of the second plug (12) of the container (1).
- A system according to any one of the preceding claims in which a rubber cap (6) covers the lower cannula needle (34) to prevent fluid leak from the container (1) through the cannula lest the second plug (12) be pierced before the first plug (22).
- A system according to any one of the preceding claims having a stopper means (47) which, when the slide member (3) has moved towards the vial (2) to a predetermined position in which the lower cannula needle (34) fully pierces the first plug (22) of the vial (2), locks the slide member (3) with respect to the capsule (4).
- A system according to claim 9 in which the stopper means (47) includes an annular recess around the interior of the capsule (4) into which the slide member (3) locks at said position.
- A system according to any one of claims 1 to 7 in which the capsule (4) has a partition wall (41) separating the capsule into a vial mount section (44) at the first end and a slide section (43) at the second end, the slide member (3) being slidably disposed in the slide section (43) of the capsule and the partition wall (41) having a central hole (42) through which the lower cannula needle (34) can pass for piercing the plug member (22) of the vial (2), with the slide member (3) contacting the partition wall (42) when it reaches a position corresponding to full insertion of the lower cannula needle (34) into the first plug (22) of the vial (2).
- A system according to claim 11 in which the capsule (4) has an inner cylindrical wall having an annular recess (47) into which the slide member (3) makes a locking engagement at said position.
- A system according to claim 12 in which the vial mount section (44) of the capsule (4) has a female thread (46) and the vial (2) has a male thread (23) to make said connection between the vial (2) and the capsule (4).
- A system according to claim 13 in which the male and female thread portions (23,46) are arranged such that when the vial (2) is fixedly connected by the threaded connection, the first plug member (22) of the vial (2) contacts the partition wall (41) of the capsule (4).
- A system according to any one of claims 1 to 7 in which the container (1) has a cylindrical wall portion and a bottom, the system including an auxiliary cover member (5) fitting over the container's cylindrical wall portion and bottom at least partially, the cover member (5) being a slidable air-tight friction fit into the second end of the capsule (4).
- A system according to claim 15 in which the inside of the capsule wall has an annular rib (45) engaged by an annular edge of the cover member (5) to restrain movement of the container (1) into the capsule (4) until the container (1) is forcibly slid further into the capsule (4) whereupon the cover member (5) can move past the annular rib (45).
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4204193 | 1993-02-05 | ||
JP4204193A JPH06239352A (en) | 1993-02-05 | 1993-02-05 | Solution injection set |
JP42041/93 | 1993-02-05 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0614653A2 EP0614653A2 (en) | 1994-09-14 |
EP0614653A3 EP0614653A3 (en) | 1995-01-04 |
EP0614653B1 true EP0614653B1 (en) | 2001-08-22 |
Family
ID=12625056
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19940300847 Expired - Lifetime EP0614653B1 (en) | 1993-02-05 | 1994-02-04 | Fluid delivery system |
Country Status (8)
Country | Link |
---|---|
US (1) | US5445631A (en) |
EP (1) | EP0614653B1 (en) |
JP (1) | JPH06239352A (en) |
AT (1) | ATE204453T1 (en) |
DE (1) | DE69428005T2 (en) |
DK (1) | DK0614653T3 (en) |
ES (1) | ES2159542T3 (en) |
PT (1) | PT614653E (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8333773B2 (en) | 2003-03-31 | 2012-12-18 | Depuy Spine, Inc. | Remotely-activated vertebroplasty injection device |
US8360629B2 (en) | 2005-11-22 | 2013-01-29 | Depuy Spine, Inc. | Mixing apparatus having central and planetary mixing elements |
US8361078B2 (en) | 2003-06-17 | 2013-01-29 | Depuy Spine, Inc. | Methods, materials and apparatus for treating bone and other tissue |
US8415407B2 (en) | 2004-03-21 | 2013-04-09 | Depuy Spine, Inc. | Methods, materials, and apparatus for treating bone and other tissue |
US8579908B2 (en) | 2003-09-26 | 2013-11-12 | DePuy Synthes Products, LLC. | Device for delivering viscous material |
US8950929B2 (en) | 2006-10-19 | 2015-02-10 | DePuy Synthes Products, LLC | Fluid delivery system |
KR102103453B1 (en) | 2010-08-25 | 2020-04-23 | 박스앨타 게엠베하 | Assembly to facilitate user reconstitution |
Families Citing this family (132)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5603695A (en) * | 1995-06-07 | 1997-02-18 | Erickson; Kim | Device for alkalizing local anesthetic injection medication |
US6277095B1 (en) | 1995-10-11 | 2001-08-21 | Science Incorporated | Fluid delivery device with full adapter |
US6132353A (en) * | 1996-10-21 | 2000-10-17 | Winkelman; James W. | Apparatus and method for separating plasma or serum from the red cells of a blood sample |
ES1037919Y (en) * | 1997-07-16 | 1998-11-01 | Inibsa Lab | TWO LIQUID CONTAINER CARTRIDGE. |
US6071270A (en) | 1997-12-04 | 2000-06-06 | Baxter International Inc. | Sliding reconstitution device with seal |
US6475183B1 (en) * | 1998-06-03 | 2002-11-05 | Baxter International Inc. | Direct dual filling device for sealing agents |
US20050137566A1 (en) | 2003-12-23 | 2005-06-23 | Fowles Thomas A. | Sliding reconstitution device for a diluent container |
US6113583A (en) | 1998-09-15 | 2000-09-05 | Baxter International Inc. | Vial connecting device for a sliding reconstitution device for a diluent container |
AR021220A1 (en) | 1998-09-15 | 2002-07-03 | Baxter Int | CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER. |
US6253804B1 (en) * | 1999-11-05 | 2001-07-03 | Minimed Inc. | Needle safe transfer guard |
US6453956B2 (en) * | 1999-11-05 | 2002-09-24 | Medtronic Minimed, Inc. | Needle safe transfer guard |
US6575205B2 (en) | 2000-12-07 | 2003-06-10 | Baxter International | Direct dual filling device for sealing agents |
FR2819174B1 (en) * | 2001-01-08 | 2003-06-13 | Pierre Frezza | BULB FOR PACKAGING AND TRANSFERRING LIQUID OR POWDER FOR MEDICAL USE IN A CONTAINER |
US6474375B2 (en) | 2001-02-02 | 2002-11-05 | Baxter International Inc. | Reconstitution device and method of use |
DE10124944C2 (en) * | 2001-05-21 | 2003-06-26 | 3M Espe Ag | Opening device for a container |
CH695288A5 (en) * | 2001-08-21 | 2006-03-15 | Tecpharma Licensing Ag | Fixing device for injection needles. |
DE10142450C1 (en) * | 2001-08-31 | 2003-06-18 | Aventis Behring Gmbh | Device for bringing components together under sterile conditions |
US6984063B2 (en) * | 2002-10-07 | 2006-01-10 | Advanced Biomaterial Systems, Inc. | Apparatus for mixing and dispensing components |
US6572256B2 (en) * | 2001-10-09 | 2003-06-03 | Immedica | Multi-component, product handling and delivering system |
US7029163B2 (en) * | 2002-10-07 | 2006-04-18 | Advanced Biomaterial Systems, Inc. | Apparatus for mixing and dispensing components |
US6644365B1 (en) | 2002-04-19 | 2003-11-11 | Baxter International, Inc. | Tilting direct dual filling device |
US7048724B2 (en) * | 2002-12-17 | 2006-05-23 | Denver Biomedicals, Inc. | Device for withdrawing body fluids |
ES2545328T3 (en) | 2003-03-14 | 2015-09-10 | Depuy Spine, Inc. | Bone cement hydraulic injection device in percutaneous vertebroplasty |
US6948522B2 (en) * | 2003-06-06 | 2005-09-27 | Baxter International Inc. | Reconstitution device and method of use |
US7641851B2 (en) | 2003-12-23 | 2010-01-05 | Baxter International Inc. | Method and apparatus for validation of sterilization process |
DE102004005435B3 (en) * | 2004-02-04 | 2005-09-15 | Haindl, Hans, Dr. | Medical transfer device |
FR2867396B1 (en) * | 2004-03-10 | 2006-12-22 | P2A | PERFORATING PERFORMER WITH STERILE CONNECTION |
US8142462B2 (en) * | 2004-05-28 | 2012-03-27 | Cavitech, Llc | Instruments and methods for reducing and stabilizing bone fractures |
US7731678B2 (en) | 2004-10-13 | 2010-06-08 | Hyprotek, Inc. | Syringe devices and methods for mixing and administering medication |
WO2006063504A1 (en) * | 2004-12-16 | 2006-06-22 | Zhongshan Botai Pharmaceutic Instruments Co., Ltd. | Medicine mixer for applying drug |
US7597680B2 (en) * | 2005-02-09 | 2009-10-06 | Kaken Pharmaceutical Co., Ltd. | Syringe device and method of preparing medicine using the device |
US8840586B2 (en) | 2006-08-23 | 2014-09-23 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US9381024B2 (en) | 2005-07-31 | 2016-07-05 | DePuy Synthes Products, Inc. | Marked tools |
US9918767B2 (en) | 2005-08-01 | 2018-03-20 | DePuy Synthes Products, Inc. | Temperature control system |
CN101365503B (en) | 2005-11-09 | 2012-02-29 | 海浦德科公司 | Syringe devices, components of syringe devices, and methods of forming components and syringe devices |
EP2540276B1 (en) | 2006-05-25 | 2016-03-16 | Bayer Healthcare LLC | Method of assembling a reconstitution device |
AT503915B1 (en) * | 2006-06-21 | 2008-02-15 | Friedrich Ing Pipelka | Transfer device for transferring a fluid from one container to another container comprises locking protrusions arranged in an adapter for locking a container in holders of the adapter |
DE102006031712B3 (en) * | 2006-07-08 | 2007-12-06 | Haindl, Hans, Dr.med. Dipl.-Ing. | Fluid transfer device, has guide, block and anti-block that are provided to block movement of transfer part in direction of bottle containing medicament and to release movement when pin transfixes connector of bottle containing fluid |
DE102006035545B4 (en) * | 2006-07-27 | 2008-04-30 | Csl Behring Gmbh | Device for bringing components together by means of negative pressure under sterile conditions |
US7828764B2 (en) | 2006-08-23 | 2010-11-09 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
DK2061536T3 (en) * | 2006-08-23 | 2012-02-06 | Medtronic Minimed Inc | Plant and method for filling containers and for dispensing an infusion medium |
US7811262B2 (en) | 2006-08-23 | 2010-10-12 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7794434B2 (en) | 2006-08-23 | 2010-09-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
CA2663447A1 (en) | 2006-09-14 | 2008-03-20 | Depuy Spine, Inc. | Polymeric bone cement and methods of use thereof |
IL182605A0 (en) | 2007-04-17 | 2007-07-24 | Medimop Medical Projects Ltd | Fluid control device with manually depressed actuator |
EP2188004A4 (en) | 2007-08-21 | 2015-06-17 | Yukon Medical Llc | Vial access and injection system |
WO2009038860A2 (en) | 2007-09-18 | 2009-03-26 | Medeq Llc | Medicament mixing and injection apparatus |
DE102007046951B3 (en) * | 2007-10-01 | 2009-02-26 | B. Braun Melsungen Ag | Device for introducing a medicament into an infusion container |
US9522097B2 (en) | 2007-10-04 | 2016-12-20 | Hyprotek, Inc. | Mixing/administration syringe devices, protective packaging and methods of protecting syringe handlers |
US8639387B2 (en) * | 2007-11-02 | 2014-01-28 | Vkr Holding A/S | Method, system and device for controlling a device related to a building aperture |
US8870832B2 (en) * | 2007-11-08 | 2014-10-28 | Elcam Medical A.C.A.L Ltd | Vial adaptor and manufacturing method therefor |
DE102008029856B4 (en) * | 2008-02-27 | 2010-10-28 | Arnold Jahn | Bottle and system for producing a mixed drink |
JP5685522B2 (en) | 2008-04-01 | 2015-03-18 | ユーコン・メディカル,リミテッド・ライアビリティ・カンパニー | Duplex container fluid transfer device |
US8141601B2 (en) | 2008-10-02 | 2012-03-27 | Roche Diagnostics Operations, Inc. | Manual filling aid with push button fill |
WO2010052707A1 (en) * | 2008-11-04 | 2010-05-14 | Situ Gen Ltd. | Dually activated connector |
JP5685579B2 (en) | 2009-04-14 | 2015-03-18 | ユーコン・メディカル,リミテッド・ライアビリティ・カンパニー | Fluid transfer device |
JP5333850B2 (en) * | 2009-07-15 | 2013-11-06 | ニプロ株式会社 | Connecting device |
JP5981341B2 (en) * | 2009-09-14 | 2016-08-31 | ネステク ソシエテ アノニム | Package with foil seal and penetration means |
FR2950328A1 (en) * | 2009-09-21 | 2011-03-25 | Hcl Group | Dosing system for use at neck of container e.g. plastic bottle, has maintenance and guidance units, and exertion units that are provided for exerting mechanical action on container to facilitate release of product |
IL201323A0 (en) | 2009-10-01 | 2010-05-31 | Medimop Medical Projects Ltd | Fluid transfer device for assembling a vial with pre-attached female connector |
AU2010310457B2 (en) | 2009-10-23 | 2015-07-02 | Amgen Inc. | Vial adapter and system |
IL202069A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Fluid transfer device with sealing arrangement |
IL202070A0 (en) | 2009-11-12 | 2010-06-16 | Medimop Medical Projects Ltd | Inline liquid drug medical device |
US8424713B2 (en) * | 2009-12-17 | 2013-04-23 | Michael J. Bolland | Multiple container retaining device and method for using same |
EP2353629A1 (en) * | 2010-02-08 | 2011-08-10 | Fresenius Kabi Deutschland GmbH | Connector for containers containing medical agents |
WO2011104711A1 (en) | 2010-02-24 | 2011-09-01 | Medimop Medical Projects Ltd | Fluid transfer assembly with venting arrangement |
CN102781396B (en) | 2010-02-24 | 2015-01-07 | 麦迪麦珀医疗工程有限公司 | Liquid drug transfer device with vented vial adapter |
USD655017S1 (en) | 2010-06-17 | 2012-02-28 | Yukon Medical, Llc | Shroud |
US8734420B2 (en) | 2010-08-25 | 2014-05-27 | Baxter International Inc. | Packaging assembly to prevent premature activation |
USD669980S1 (en) | 2010-10-15 | 2012-10-30 | Medimop Medical Projects Ltd. | Vented vial adapter |
IL209290A0 (en) | 2010-11-14 | 2011-01-31 | Medimop Medical Projects Ltd | Inline liquid drug medical device having rotary flow control member |
AU2012225163B2 (en) * | 2011-03-04 | 2016-05-12 | Duoject Medical Systems Inc. | Easy linking transfer system |
WO2012132829A1 (en) * | 2011-03-25 | 2012-10-04 | テルモ株式会社 | Double-ended needle and mixing instrument |
MX341790B (en) | 2011-03-31 | 2016-09-02 | Amgen Inc | Vial adapter and system. |
PL2510914T3 (en) | 2011-04-12 | 2015-02-27 | Hoffmann La Roche | Connector device |
IL212420A0 (en) | 2011-04-17 | 2011-06-30 | Medimop Medical Projects Ltd | Liquid drug transfer assembly |
USD681230S1 (en) | 2011-09-08 | 2013-04-30 | Yukon Medical, Llc | Shroud |
IL215699A0 (en) | 2011-10-11 | 2011-12-29 | Medimop Medical Projects Ltd | Liquid drug reconstitution assemblage for use with iv bag and drug vial |
USD674088S1 (en) | 2012-02-13 | 2013-01-08 | Medimop Medical Projects Ltd. | Vial adapter |
USD720451S1 (en) | 2012-02-13 | 2014-12-30 | Medimop Medical Projects Ltd. | Liquid drug transfer assembly |
USD737436S1 (en) | 2012-02-13 | 2015-08-25 | Medimop Medical Projects Ltd. | Liquid drug reconstitution assembly |
KR101763459B1 (en) * | 2012-02-22 | 2017-07-31 | 박스알타 인코퍼레이티드 | Packaging assembly to prevent premature activation |
IL219065A0 (en) | 2012-04-05 | 2012-07-31 | Medimop Medical Projects Ltd | Fluid transfer device with manual operated cartridge release arrangement |
USD769444S1 (en) | 2012-06-28 | 2016-10-18 | Yukon Medical, Llc | Adapter device |
IL221635A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Drug vial mixing and transfer device for use with iv bag and drug vial |
IL221634A0 (en) | 2012-08-26 | 2012-12-31 | Medimop Medical Projects Ltd | Universal drug vial adapter |
EP2872100B1 (en) | 2012-09-13 | 2017-03-29 | Medimop Medical Projects Ltd | Telescopic female drug vial adapter |
USD734868S1 (en) | 2012-11-27 | 2015-07-21 | Medimop Medical Projects Ltd. | Drug vial adapter with downwardly depending stopper |
JP2014144029A (en) * | 2013-01-25 | 2014-08-14 | Inter Medic Co Ltd | Solution container with double-ended needle |
IL225734A0 (en) | 2013-04-14 | 2013-09-30 | Medimop Medical Projects Ltd | Ready-to-use drug vial assemblages including drug vial and drug vial closure having fluid transfer member, and drug vial closure therefor |
CN105228676B (en) | 2013-05-10 | 2018-01-05 | 麦迪麦珀医疗工程有限公司 | Include the medical treatment device of the vial adapter with inline dry kit |
USD767124S1 (en) | 2013-08-07 | 2016-09-20 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
CN205626622U (en) | 2013-08-07 | 2016-10-12 | 麦迪麦珀医疗工程有限公司 | Liquid transfer device that is used together with infusion container |
USD765837S1 (en) | 2013-08-07 | 2016-09-06 | Medimop Medical Projects Ltd. | Liquid transfer device with integral vial adapter |
WO2015085110A1 (en) * | 2013-12-04 | 2015-06-11 | Wayne State University | Fluid sample transfer adaptor and related methods and devices |
USD794183S1 (en) | 2014-03-19 | 2017-08-08 | Medimop Medical Projects Ltd. | Dual ended liquid transfer spike |
DE102014104281B3 (en) * | 2014-03-27 | 2015-09-10 | Medac Gesellschaft für klinische Spezialpräparate mbH | transfer device |
CA159103S (en) * | 2014-04-29 | 2015-06-01 | Bayer Animal Health Gmbh | Transfer device |
EP2944301B1 (en) * | 2014-05-14 | 2017-07-19 | Becton Dickinson Rowa Germany GmbH | Holder for a medicine container |
USD757933S1 (en) | 2014-09-11 | 2016-05-31 | Medimop Medical Projects Ltd. | Dual vial adapter assemblage |
CN104340540B (en) * | 2014-10-31 | 2017-05-17 | 佛山市塑冠包装有限公司 | Instant liquid mixing beverage bottle and filling method thereof |
BR112017013534B1 (en) | 2015-01-05 | 2021-12-21 | Medimop Medical Projects Ltd. | ASSEMBLING THE DOUBLE BOTTLE ADAPTER FOR USE WITH ONE MEDICATION BOTTLE AND ONE LIQUID BOTTLE |
CN113143759B (en) | 2015-07-16 | 2024-01-30 | 西部制药服务以色列有限公司 | Liquid drug transfer device for secure telescopic snap-fit on an injection vial |
EP3324915A1 (en) * | 2015-07-20 | 2018-05-30 | Medimop Medical Projects Ltd. | Liquid drug transfer device with set-up vial retention flex members |
CN105125340A (en) * | 2015-09-10 | 2015-12-09 | 成都华神生物技术有限责任公司 | Medicine solution preparing device, using method thereof, medicine using device and using method thereof |
USD801522S1 (en) | 2015-11-09 | 2017-10-31 | Medimop Medical Projects Ltd. | Fluid transfer assembly |
JP6523569B2 (en) | 2015-11-25 | 2019-06-05 | ウエスト・ファーマ.サービシーズ・イスラエル,リミテッド | Dual vial adapter assembly comprising a vial adapter having a self sealing access valve |
BE1023649B1 (en) * | 2015-12-03 | 2017-06-06 | Trasis S.A. | PERFORATING NEEDLE FOR FLASK WITH SEPTUM |
IL245800A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including identical twin vial adapters |
IL245803A0 (en) | 2016-05-24 | 2016-08-31 | West Pharma Services Il Ltd | Dual vial adapter assemblages including vented drug vial adapter and vented liquid vial adapter |
IL246073A0 (en) | 2016-06-06 | 2016-08-31 | West Pharma Services Il Ltd | Fluid transfer devices for use with drug pump cartridge having slidable driving plunger |
BR102016017044A2 (en) * | 2016-07-22 | 2018-02-06 | Blastinfusion International Industria E Comercio De Artefatos Plasticos Eireli | MIXER DEVICE AND MIXING METHOD OF TWO SUBSTANCES |
IL247376A0 (en) | 2016-08-21 | 2016-12-29 | Medimop Medical Projects Ltd | Syringe assembly |
USD832430S1 (en) | 2016-11-15 | 2018-10-30 | West Pharma. Services IL, Ltd. | Dual vial adapter assemblage |
IL249408A0 (en) | 2016-12-06 | 2017-03-30 | Medimop Medical Projects Ltd | Liquid transfer device for use with infusion liquid container and pincers-like hand tool for use therewith for releasing intact drug vial therefrom |
US11701301B2 (en) * | 2017-03-06 | 2023-07-18 | All India Institute Of Medical Sciences (Aiims) | Device, method and kit for the reconstitution of a solid or semi solid pharmaceutical composition |
IL251458A0 (en) | 2017-03-29 | 2017-06-29 | Medimop Medical Projects Ltd | User actuated liquid drug transfer devices for use in ready-to-use (rtu) liquid drug transfer assemblages |
IL254802A0 (en) | 2017-09-29 | 2017-12-31 | Medimop Medical Projects Ltd | Dual vial adapter assemblages with twin vented female vial adapters |
US20190298611A1 (en) * | 2018-03-28 | 2019-10-03 | Mikael NAYGAUZ | Devices and systems for contaminant-free engagement and fluid transfer of pharmaceutical vessels and pharmaceutical administration devices |
USD903864S1 (en) | 2018-06-20 | 2020-12-01 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
JP1630477S (en) | 2018-07-06 | 2019-05-07 | ||
USD901312S1 (en) | 2018-12-07 | 2020-11-10 | Sage Products, Llc | Packaging for oral care device |
USD923812S1 (en) | 2019-01-16 | 2021-06-29 | West Pharma. Services IL, Ltd. | Medication mixing apparatus |
JP1648075S (en) | 2019-01-17 | 2019-12-16 | ||
WO2020157719A1 (en) | 2019-01-31 | 2020-08-06 | West Pharma. Services Il, Ltd | Liquid transfer device |
USD988868S1 (en) | 2019-03-11 | 2023-06-13 | Sage Products, Llc | Packaging for oral care device |
CA3135248C (en) | 2019-04-30 | 2024-01-02 | Yossi Bar-El | Liquid transfer device with dual lumen iv spike |
GB201918663D0 (en) * | 2019-12-17 | 2020-01-29 | Oribiotech Ltd | A connector |
USD956958S1 (en) | 2020-07-13 | 2022-07-05 | West Pharma. Services IL, Ltd. | Liquid transfer device |
HUE065035T2 (en) | 2021-07-26 | 2024-04-28 | Kairish Innotech Private Ltd | Component mixing apparatus and system including a cannula for fluid transfer |
KR102404906B1 (en) * | 2021-07-28 | 2022-06-02 | 안소호 | Safety socket for connecting medicine bottle enabling separation collection of waste disposal |
WO2023028009A1 (en) * | 2021-08-25 | 2023-03-02 | Scatter, LLC | Connectors and methods for contactless transfer of fluid between containers |
Family Cites Families (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3872867A (en) * | 1971-06-02 | 1975-03-25 | Upjohn Co | Wet-dry additive assembly |
AR205565A1 (en) * | 1974-04-29 | 1976-05-14 | Abbott Lab | STORAGE AND TRANSFER UNIT FOR AN ADDITIVE PARTICULARLY APPLICABLE TO TRANSFER OF MEDICINES |
NL173477C (en) * | 1974-09-12 | 1984-02-01 | Duphar Int Res | INJECTION SYRINGE WITH TELESCOPIC BODY BETWEEN CARTRIDGE AND MEDICINE BOTTLE. |
FR2293916A1 (en) * | 1974-12-12 | 1976-07-09 | Boisnard Jean Yves | Powder and solvent mixing equipment - has sheath with piercing device for bottles inserted at ends |
US4615267A (en) * | 1982-11-08 | 1986-10-07 | Venture Vii, Ltd. | Portable data recorder |
ZA84810B (en) * | 1983-02-28 | 1984-10-31 | Abbott Lab | Dual compartmented container |
US4583971A (en) * | 1984-02-10 | 1986-04-22 | Travenol European Research And Development Centre (Teradec) | Closed drug delivery system |
IE57676B1 (en) * | 1984-03-19 | 1993-02-24 | Abbott Lab | Drug delivery system |
US4614437A (en) * | 1984-11-02 | 1986-09-30 | Dougherty Brothers Company | Mixing container and adapter |
US4675020A (en) * | 1985-10-09 | 1987-06-23 | Kendall Mcgaw Laboratories, Inc. | Connector |
US4757911A (en) * | 1985-12-09 | 1988-07-19 | Abbott Laboratories | Container and closure construction |
JPH0422745Y2 (en) * | 1986-09-05 | 1992-05-26 | ||
JPS63135642A (en) * | 1986-11-21 | 1988-06-08 | Yanmar Diesel Engine Co Ltd | Safety device for belt type continuously variable transmission |
EP0352322B1 (en) * | 1986-12-11 | 1994-09-21 | Terumo Kabushiki Kaisha | Blood sampling tube |
IL88667A (en) * | 1987-12-28 | 1992-02-16 | Abbott Lab | Container with improved ratchet teeth interlock |
JPH021277A (en) * | 1988-03-31 | 1990-01-05 | Fujisawa Pharmaceut Co Ltd | Infusion container |
DE3817101C2 (en) * | 1988-05-19 | 1998-05-20 | Axel Von Brand | Device for transferring liquid from one container to another container |
JPH0740970B2 (en) * | 1988-07-15 | 1995-05-10 | 株式会社ノダ | Storage shelf equipment |
JPH0337067A (en) * | 1989-07-03 | 1991-02-18 | Hishiyama Seiyaku Kk | Transfusion container |
JPH0422745A (en) * | 1990-05-17 | 1992-01-27 | Mitsubishi Electric Corp | Misfire detection method for internal combustion engine |
JPH04126545A (en) * | 1990-09-14 | 1992-04-27 | Mitsubishi Kasei Corp | Production of liposome |
US5171214A (en) * | 1990-12-26 | 1992-12-15 | Abbott Laboratories | Drug storage and delivery system |
US5354287A (en) * | 1991-01-16 | 1994-10-11 | Senetek Plc | Injector for delivering fluid to internal target tissue |
JPH04282160A (en) * | 1991-03-08 | 1992-10-07 | Material Eng Tech Lab Inc | Transfusion liquid container |
JPH04329956A (en) * | 1991-04-30 | 1992-11-18 | Takeda Chem Ind Ltd | Germ-free holding/mixing apparatus for medicine held in individual sealed container |
CA2093560C (en) * | 1992-04-10 | 2005-06-07 | Minoru Honda | Fluid container |
JP2605345Y2 (en) * | 1992-05-01 | 2000-07-10 | 株式会社大塚製薬工場 | Drug container |
-
1993
- 1993-02-05 JP JP4204193A patent/JPH06239352A/en active Pending
-
1994
- 1994-02-04 DK DK94300847T patent/DK0614653T3/en active
- 1994-02-04 AT AT94300847T patent/ATE204453T1/en not_active IP Right Cessation
- 1994-02-04 DE DE69428005T patent/DE69428005T2/en not_active Expired - Fee Related
- 1994-02-04 ES ES94300847T patent/ES2159542T3/en not_active Expired - Lifetime
- 1994-02-04 PT PT94300847T patent/PT614653E/en unknown
- 1994-02-04 EP EP19940300847 patent/EP0614653B1/en not_active Expired - Lifetime
- 1994-02-04 US US08/192,282 patent/US5445631A/en not_active Expired - Fee Related
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8333773B2 (en) | 2003-03-31 | 2012-12-18 | Depuy Spine, Inc. | Remotely-activated vertebroplasty injection device |
US8361078B2 (en) | 2003-06-17 | 2013-01-29 | Depuy Spine, Inc. | Methods, materials and apparatus for treating bone and other tissue |
US8540722B2 (en) | 2003-06-17 | 2013-09-24 | DePuy Synthes Products, LLC | Methods, materials and apparatus for treating bone and other tissue |
US8579908B2 (en) | 2003-09-26 | 2013-11-12 | DePuy Synthes Products, LLC. | Device for delivering viscous material |
US8415407B2 (en) | 2004-03-21 | 2013-04-09 | Depuy Spine, Inc. | Methods, materials, and apparatus for treating bone and other tissue |
US8360629B2 (en) | 2005-11-22 | 2013-01-29 | Depuy Spine, Inc. | Mixing apparatus having central and planetary mixing elements |
US8950929B2 (en) | 2006-10-19 | 2015-02-10 | DePuy Synthes Products, LLC | Fluid delivery system |
KR102103453B1 (en) | 2010-08-25 | 2020-04-23 | 박스앨타 게엠베하 | Assembly to facilitate user reconstitution |
KR102253635B1 (en) | 2010-08-25 | 2021-05-20 | 박스앨타 게엠베하 | Assembly to facilitate user reconstitution |
Also Published As
Publication number | Publication date |
---|---|
ES2159542T3 (en) | 2001-10-16 |
PT614653E (en) | 2001-12-28 |
ATE204453T1 (en) | 2001-09-15 |
US5445631A (en) | 1995-08-29 |
JPH06239352A (en) | 1994-08-30 |
EP0614653A3 (en) | 1995-01-04 |
DK0614653T3 (en) | 2001-10-08 |
DE69428005T2 (en) | 2001-12-06 |
EP0614653A2 (en) | 1994-09-14 |
DE69428005D1 (en) | 2001-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0614653B1 (en) | Fluid delivery system | |
EP0897708B1 (en) | Drug delivery container having a luer filter | |
US4392850A (en) | In-line transfer unit | |
JP5213622B2 (en) | Equipment for the preparation of pharmaceutical agents | |
US4392851A (en) | In-line transfer unit | |
EP0195018B1 (en) | Reconstitution device | |
EP3494951B1 (en) | System for closed transfer of fluids | |
US5487737A (en) | Storage and transfer bottle designed for storing a component of a medicamental substance | |
AU720748B2 (en) | Container closure system | |
EP0592689B1 (en) | Vessel for drug | |
JP5518708B2 (en) | Drug mixing system | |
US5472431A (en) | Insert device for facilitating limited aspiration of a delivery apparatus | |
EP0829248B1 (en) | A transfer assembly for a medicament container having a splashless valve | |
JPH05317383A (en) | Solution container equipped with means for communicating with chemical container | |
EP3581225B1 (en) | Pre-filled diluent syringe vial adapter | |
JPH08126683A (en) | Container for transfusion | |
US6464105B1 (en) | Device for withdrawing a ready liquid medicament from a receptacle provided with a pierceable membrane | |
JP3565609B2 (en) | Lysis solution injection set | |
EP3562752B1 (en) | Container closure operated by rotation | |
EP4124330A1 (en) | Component mixing apparatus and system including a cannula for fluid transfer | |
WO1994000094A1 (en) | A reconstitution device | |
JPH10295780A (en) | Fluid transportation device accessing fluid from vial and ampul and method to transport fluid using the same device | |
JPH06343678A (en) | Vessel for infusion liquid | |
JP3146431B2 (en) | Drug container with communication means | |
JPH05176972A (en) | Container for medical purpose |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 19950704 |
|
17Q | First examination report despatched |
Effective date: 19990520 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE |
|
REF | Corresponds to: |
Ref document number: 204453 Country of ref document: AT Date of ref document: 20010915 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: E. BLUM & CO. PATENTANWAELTE Ref country code: CH Ref legal event code: EP |
|
REF | Corresponds to: |
Ref document number: 69428005 Country of ref document: DE Date of ref document: 20010927 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2159542 Country of ref document: ES Kind code of ref document: T3 |
|
ET | Fr: translation filed | ||
NLT1 | Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1 |
Owner name: NIPRO CORPORATION;SUNTORY LIMITED |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20011002 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
RAP2 | Party data changed (patent owner data changed or rights of a patent transferred) |
Owner name: NIPRO CORPORATION Owner name: SUNTORY LIMITED |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD Ref country code: FR Ref legal event code: CA |
|
REG | Reference to a national code |
Ref country code: GR Ref legal event code: EP Ref document number: 20010402123 Country of ref document: GR |
|
NLT2 | Nl: modifications (of names), taken from the european patent patent bulletin |
Owner name: SUNTORY LIMITED EN NIPRO CORPORATION |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: PT Ref legal event code: PC4A Free format text: NIPRO CORPORATION JP Effective date: 20020801 |
|
BECA | Be: change of holder's address |
Owner name: 3-3-13, TOYOSAKI, KITA-KU, OSAKA-SHI Effective date: 20030402 Owner name: *NIPRO CORP.7-2 KOJIMACHI 5-CHOME, JP - CHIYODA-KU Effective date: 20030402 Owner name: *DAIICHI SUNTORY PHARMA CO. LTD Effective date: 20030402 |
|
BECH | Be: change of holder |
Owner name: *NIPRO CORP. Effective date: 20030402 Owner name: *DAIICHI SUNTORY PHARMA CO. LTD Effective date: 20030402 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: SUNTORY LIMITED Free format text: SUNTORY LIMITED#1-40, DOJIMAHAMA 2-CHOME#KITA-KU, OSAKA-SHI, OSAKA (JP) $ NISSHO CORPORATION#9-3, HONJONISHI 3-CHOME KITA-KU#OSAKA-SHI OSAKA 531 (JP) -TRANSFER TO- SUNTORY LIMITED#1-40, DOJIMAHAMA 2-CHOME#KITA-KU, OSAKA-SHI, OSAKA (JP) $ NIPRO CORPORATION#3-3-13, TOYOSAKI, KITA-KU#OSAKA-SHI (JP) |
|
NLS | Nl: assignments of ep-patents |
Owner name: NIPRO CORPORATION Owner name: DAIICHI SUNTORY PHARMA CO., LTD. |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PUE Owner name: DAIICHI SUNTORY PHARMA CO., LTD. Free format text: SUNTORY LIMITED#1-40, DOJIMAHAMA 2-CHOME#KITA-KU, OSAKA-SHI, OSAKA (JP) $ NIPRO CORPORATION#3-3-13, TOYOSAKI, KITA-KU#OSAKA-SHI (JP) -TRANSFER TO- DAIICHI SUNTORY PHARMA CO., LTD.#7-2, KOJIMACHI 5-CHOME#CHIYODA-KU, TOKYO (JP) $ NIPRO CORPORATION#3-3-13, TOYOSAKI, KITA-KU#OSAKA-SHI (JP) Ref country code: CH Ref legal event code: NV Representative=s name: ARNOLD & SIEDSMA AG |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: TP |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20050204 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20060123 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PFA Owner name: NIPRO CORPORATION Free format text: DAIICHI SUNTORY PHARMA CO., LTD.#7-2, KOJIMACHI 5-CHOME#CHIYODA-KU, TOKYO (JP) $ NIPRO CORPORATION#3-3-13, TOYOSAKI, KITA-KU#OSAKA-SHI (JP) -TRANSFER TO- NIPRO CORPORATION#3-3-13, TOYOSAKI, KITA-KU#OSAKA-SHI (JP) $ DAIICHI ASUBIO PHARMA CO., LTD.#9-11, AKASAKA 2-CHOME, MINATO-KU#TOKYO (JP) |
|
NLT1 | Nl: modifications of names registered in virtue of documents presented to the patent office pursuant to art. 16 a, paragraph 1 |
Owner name: NIPRO CORPORATION Owner name: DAIICHI ASUBIO PHARMA CO., LTD. |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20060201 Year of fee payment: 13 Ref country code: GB Payment date: 20060201 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: 732E |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20060202 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: SE Payment date: 20060207 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: AT Payment date: 20060213 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20060215 Year of fee payment: 13 Ref country code: DK Payment date: 20060215 Year of fee payment: 13 Ref country code: CH Payment date: 20060215 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20060220 Year of fee payment: 13 Ref country code: FR Payment date: 20060220 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20060221 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20060302 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20060410 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: CD Ref country code: FR Ref legal event code: CA |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: PC2A |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070205 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070228 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070806 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20070806 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL Ref country code: DK Ref legal event code: EBP |
|
EUG | Se: european patent has lapsed | ||
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20070204 |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 20070901 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070204 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20071030 |
|
BERE | Be: lapsed |
Owner name: *NIPRO CORP. Effective date: 20070228 Owner name: *DAIICHI ASUBIO PHARMA CO. LTD Effective date: 20070228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070228 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070901 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070205 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070228 Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070901 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070204 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070228 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20060228 Year of fee payment: 13 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20080301 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20070205 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070205 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070904 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20070204 |
|
PGRI | Patent reinstated in contracting state [announced from national office to epo] |
Ref country code: IT Effective date: 20080301 |